SAN JOSE, November 13, 2006, (PodTech News)–Are the Starz aligned for downloading movies? At last week’s Dow Jones VentureWire Consumer Technology Conference is San Jose, Bob Clasen, Starz‘ president and CEO, spoke with PodTech’s Matt Kelly about the company’s acquisition [See the full post…]

What happens when you get a bunch of experts in a room and ask them all sorts of questions, like: when will I be able to watch shows over the Internet? You realize how complex things are, how little you [See the full post…]

SAN JOSE, November 9th, 2006 (PodTech News)–Modern consumers are not only tech savvy, they’re also thirsty to be tuned in, unplugged, and turned on at all times and instantly with innovative digital products. This past week Dow Jones brought together [See the full post…]

The Web 2.0 mantra is that old media — NBC, Hearst, Disney, etc. — are too incompetent to be successful on the Web. The reality is that old media has invested a lot of time, effort and money in positioning [See the full post…]

SAN JOSE, November 8, 2006 (PodTech News)–Sony launches the PlayStation 3 later this month — its most important product launch in years. Featuring Blu-ray technology and other features, the new device has a lot is riding on it. Sony Computer [See the full post…]

Understanding what consumers are doing with new media is instrumental. Speaking together at the Dow Jones VentureWire Consumer Technology Ventures Conference, Larry Gerbrandt tells PodTech’s Jennifer Jones about iPod research that will move the needle for executives assessing podcasts. Click [See the full post…]

Yahoo is making headway by being bold and thinking young. Jennifer Jones of PodTech interviews Marco Boerries at the Dow Jones Venture Wire Consumer Technology Ventures Conference about Yahoo’s strategies for connecting users whether they are on the road, at [See the full post…]

Tengion is a leader in the field of regenerative medicine, developing new human tissues and organs derived from a patient’s own cells. Tengion’s patented technology has the potential to allow adults and children with organ failure to have functioning organs [See the full post…]

Despite President Bush’s veto of the embryonic stem cell bill almost two months ago, many venture capitalists consider the stem cell market to be viable… though just not yet for some investors. When and why will a venture capitalist invest [See the full post…]

Venture capitalist Andy Kessler says silicon is going to do to the health care industry what it has done to portable devices and the Internet. Where will it start? With diagnostics, according to Kessler, who delivered the lunch keynote at [See the full post…]

Getting money for a Series B round in health care deals results in a “down round” at least 50 percent of the time. Ralph (Chris) Christoffersen, a general partner at Morgenthaler Ventures, tells PodTech’s Jennifer Jones how his firm helps [See the full post…]

Patients desire improved treatments, voters call for safety, biomed startups want drug approval to continue in business and big pharma is after big profits. The Food and Drug Administration must grapple with these issues, which are only getting more complex. [See the full post…]

The U.S. Food and Drug Administration says it is a constant balancing act to determine how much risk to consumers is acceptable in the drug approval process. No risk would result in few drugs coming to market. Some risk allows [See the full post…]